VentriPoint Enterprise Value Over E B I T D A from 2010 to 2024
| VPT Stock | CAD 0.10 0.01 11.11% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (9.58) | Current Value (9.10) | Quarterly Volatility 6.12794838 |
Check VentriPoint Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VentriPoint Diagnostics' main balance sheet or income statement drivers, such as Other Operating Expenses of 3.3 M, Total Operating Expenses of 3.2 M or Income Tax Expense of 2.85, as well as many indicators such as Price To Sales Ratio of 988, Dividend Yield of 0.0 or PTB Ratio of 256. VentriPoint financial statements analysis is a perfect complement when working with VentriPoint Diagnostics Valuation or Volatility modules.
VentriPoint | Enterprise Value Over E B I T D A |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.